
### [MONDO:0015123](http://purl.obolibrary.org/obo/MONDO_0015123)
**Label:** rare dyslipidemia

**Subclasses:** [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0018479](http://purl.obolibrary.org/obo/MONDO_0018479) (congenital adrenal hyperplasia), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0019247](http://purl.obolibrary.org/obo/MONDO_0019247) (combined hyperlipidemia), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017774](http://purl.obolibrary.org/obo/MONDO_0017774) (hypobetalipoproteinemia), [MONDO:0017773](http://purl.obolibrary.org/obo/MONDO_0017773) (hypoalphalipoproteinemia), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0019174](http://purl.obolibrary.org/obo/MONDO_0019174) (infantile Refsum disease), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0009958](http://purl.obolibrary.org/obo/MONDO_0009958) (Refsum disease), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0015905](http://purl.obolibrary.org/obo/MONDO_0015905) (rare syndromic dyslipidemia), [MONDO:0015904](http://purl.obolibrary.org/obo/MONDO_0015904) (rare hypolipidemia), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901) (rare hyperlipidemia), [MONDO:0010204](http://purl.obolibrary.org/obo/MONDO_0010204) (lysosomal acid lipase deficiency), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), 

**Corr. equiv. classes:** [Orphanet:477811](http://www.orpha.net/ORDO/Orphanet_477811), [Orphanet:79506](http://www.orpha.net/ORDO/Orphanet_79506), [Orphanet:444490](http://www.orpha.net/ORDO/Orphanet_444490), [Orphanet:181437](http://www.orpha.net/ORDO/Orphanet_181437), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [OMIM:266500](http://purl.obolibrary.org/obo/OMIM_266500), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [Orphanet:31153](http://www.orpha.net/ORDO/Orphanet_31153), [Orphanet:418](http://www.orpha.net/ORDO/Orphanet_418), [Orphanet:31154](http://www.orpha.net/ORDO/Orphanet_31154), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [Orphanet:181422](http://www.orpha.net/ORDO/Orphanet_181422), [Orphanet:275761](http://www.orpha.net/ORDO/Orphanet_275761), [Orphanet:79211](http://www.orpha.net/ORDO/Orphanet_79211), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [Orphanet:90794](http://www.orpha.net/ORDO/Orphanet_90794), [Orphanet:650](http://www.orpha.net/ORDO/Orphanet_650), [Orphanet:181428](http://www.orpha.net/ORDO/Orphanet_181428), [OMIM:201910](http://purl.obolibrary.org/obo/OMIM_201910), [Orphanet:773](http://www.orpha.net/ORDO/Orphanet_773), [Orphanet:157](http://www.orpha.net/ORDO/Orphanet_157), [Orphanet:391665](http://www.orpha.net/ORDO/Orphanet_391665), [Orphanet:772](http://www.orpha.net/ORDO/Orphanet_772), [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:181425](http://www.orpha.net/ORDO/Orphanet_181425), [OMIM:278000](http://purl.obolibrary.org/obo/OMIM_278000), [Orphanet:485631](http://www.orpha.net/ORDO/Orphanet_485631), [OMIM:143470](http://purl.obolibrary.org/obo/OMIM_143470), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [Orphanet:181431](http://www.orpha.net/ORDO/Orphanet_181431), 

**Class expressions from DL-Learner:**

- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature))) 57.62%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature))) 50.70%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 49.84%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 47.14%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 45.96%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology))) 45.35%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 45.35%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 45.35%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 45.17%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0010935](http://purl.obolibrary.org/obo/HP_0010935) (Abnormality of the upper urinary tract))) 44.53%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0000077](http://purl.obolibrary.org/obo/HP_0000077) (Abnormality of the kidney))) 44.53%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 43.76%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and (not ([HP:0001999](http://purl.obolibrary.org/obo/HP_0001999) (Abnormal facial shape))) 43.05%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 43.05%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 42.39%


